The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment
Open accessAbstract
BACKGROUND: Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year period of continuous deployment as first-line treatment in camps for displaced persons and in clinics for migrant population along the Thai-Myanmar border. METHODS AND FINDINGS: 3,264 patients were enrolled in prospective treatment trials between 1995 and 2007 and treated with MAS(3). The proportion of patients with parasitaemia persisting on day-2 increased significantly from 4.5% before 2001 to 21.9% since 2002 (p<0.001). Delayed parasite clearance was associated with increased risk of developing gametocytaemia (AOR = 2.29; 95% CI, 2.00-2.69, p = 0.002). Gametocytaemia on admission and carriage also increased over the years (p = 0.001, test for trend, for both). MAS(3) efficacy has declined slightly but significantly (Hazards ratio 1.13; 95% CI, 1.07-1.19, p<0.001), although efficacy in 2007 remained well within acceptable limits: 96.5% (95% CI, 91.0-98.7). The in vitro susceptibility of P. falciparum to artesunate increased significantly until 2002, but thereafter declined to levels close to those of 13 years ago (geometric mean in 2007: 4.2 nM/l; 95% CI, 3.2-5.5). The proportion of infections caused by parasites with increased pfmdr1 copy number rose from 30% (12/40) in 1996 to 53% (24/45) in 2006 (p = 0.012, test for trend). CONCLUSION: Artesunate-mefloquine remains a highly efficacious antimalarial treatment in this area despite 13 years of widespread intense deployment, but there is evidence of a modest increase in resistance. Of particular concern is the slowing of parasitological response to artesunate and the associated increase in gametocyte carriage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954 · cited 3×
“In 2004, MAS2 was extended to all provinces along the borders with Myanmar and Cambodia, following evidence from these areas of inadequate clinical cure rates with mefloquine alone, or MSP [4–6].”
BackgroundSelf-citationMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
Self-citationAssessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationNosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationAntimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Self-citationThe epidemiology of malaria in a Karen population on the western border of Thailand.
Luxemburger, C., Thwai, K. L., White, N. J., Webster, H. K., Kyle, D. E., Maelankirri, L., Chongsuphajaisiddhi, T., & Nosten, F. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90102-9 · Cited by 233
Self-citationNosten, F., Luxemburger, C., ter Kuile, F. O., Woodrow, C., Pa Eh, J., Chongsuphajaisiddhi, T., & White, N. J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.971 · Cited by 229
Self-citationThe assessment of antimalarial drug efficacy
White, N. J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02373-5 · Cited by 207
Self-citationBrockman, A., Price, R. N., van Vugt, M., Heppner, D. G., Walsh, D., Sookto, P., Wimonwattrawatee, T., Looareesuwan, S., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90080-4 · Cited by 185
Self-citationvan Vugt, M., Brockman, A., Gemperli, B., Luxemburger, C., Gathmann, I., Royce, C., Slight, T., Looareesuwan, S., White, N. J., & Nosten, F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.135 · Cited by 170
Self-citationArtesunate/mefloquine treatment of multi-drug resistant falciparum malaria
Price, R. N., Nosten, F., Luxemburger, C., van Vugt, M., Phaipun, L., Chongsuphajaisiddhi, T., & White, N. J. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90032-8 · Cited by 159
Self-citationThe de novo selection of drug–resistant malaria parasites
White, N. J., & Pongtavornpinyo, W. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2002.2241 · Cited by 158
Self-citationArtemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria
van Vugt, M., Looareesuwan, S., Wilairatana, P., McGready, R. M., Villegas, L., Gathmann, I., Mull, R. P., Brockman, A., White, N. J., & Nosten, F. H. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90082-8 · Cited by 153
Self-citationBrockman, A., Paul, R. E. L., Anderson, T., Hackford, I., Phaiphun, L., Looareesuwan, S., Nosten, F. H., & Day, K. P. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.60.14 · Cited by 145
Self-citationAshley, E. A., McGready, R. M., Hutagalung, R., Phaiphun, L., Slight, T., Proux, S., Thwai, K. L., Barends, M., Looareesuwan, S., White, N. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432011 · Cited by 133
Self-citation(2000) · PubMed · Cited by 125
The origins and spread of antimalarial drug resistance: Lessons for policy makers
Anderson, T., & Roper, C. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.010 · Cited by 120
Self-citationIn Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up
Stepniewska, K., Taylor, W. R. J., Mayxay, M., Price, R. N., Smithuis, F., Guthmann, J., Barnes, K. I., Myint, H. Y., Adjuik, M., Olliaro, P., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4271-4280.2004 · Cited by 120
Self-citationBarnes, K. I., Little, F., Mabuza, A. M., Mngomezulu, N., Govere, J. M., Dürrheim, D. N., Roper, C., Watkins, B., & White, N. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/587645 · Cited by 118
Self-citationVijaykadga, S., Rojanawatsirivej, C., Cholpol, S., Phoungmanee, D., Nakavej, A., & Wongsrichanalai, C. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2005.01557.x · Cited by 115
Ashley, E. A., Krudsood, S., Phaiphun, L., Srivilairit, S., McGready, R. M., Leowattana, W., Hutagalung, R., Wilairatana, P., Brockman, A., Looareesuwan, S., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/425015 · Cited by 113
Self-citationPlasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness
Preechapornkul, P., Imwong, M., Chotivanich, K., Ngum, W. P., Dondorp, A. M., Day, N., White, N. J., & Pukrittayakamee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00241-08 · Cited by 107
Self-citationHutagalung, R., Paiphun, L., Ashley, E. A., McGready, R. M., Brockman, A., Thwai, K. L., Singhasivanon, P., Jelinek, T., White, N. J., & Nosten, F. H. (2005) · Malaria Journal · doi:10.1186/1475-2875-4-46 · Cited by 93
Self-citationvan Vugt, M., Leonardi, E., Phaipun, L., Slight, T., Thway, K. L., McGready, R. M., Brockman, A., Villegas, L., Looareesuwan, S., White, N. J., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/344901 · Cited by 82
Self-citationLuxemburger, C., ter Kuile, F. O., Nosten, F. H., Dolan, G., Bradol, J. H., Phaipun, L., Chongsuphajaisiddhi, T., & White, N. J. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90303-4 · Cited by 70
Self-citationAshley, E. A., Lwin, K. M., McGready, R. M., Simon, W. H., Phaiphun, L., Proux, S., Wangseang, N., Taylor, W. R. J., Stepniewska, K., Nawamaneerat, W., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01724.x · Cited by 59
Self-citationHippocratic oaths: medicine and its discontents
Irving, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17939-2 · Cited by 42
Mefloquine--its 20 years in the Thai Malaria Control Program.
Wongsrichanalai, C., Prajakwong, S., Meshnick, S. R., Shanks, G. D., & Thimasarn, K. (2004) · PubMed · Cited by 32
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
Rojanawatsirivet, C., Congpuong, K., Vijaykadga, S., Thongphua, S., Thongsri, K., Bangchang, K. N., Wilairatana, P., & Wernsdorfer, W. H. (2004) · PubMed · Cited by 20
Rojanawatsirivej, C., Vijaykadga, S., Amklad, I., Wilairatna, P., & Looareesuwan, S. (2003) · PubMed · Cited by 18
Nosten, F. H., McGready, R. M., Ashley, E. A., & White, N. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17938-0 · Cited by 5
Self-citationDynamics of multi-drug resistance in Plasmodium falciparum in Thailand.
Rooney, W. (1992) · PubMed · Cited by 4
Cited by
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citationSpread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationThousands of chemical starting points for antimalarial lead identification
Gamo, F.-J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.-L., Vanderwall, D. E., Green, D. V. S., Kumar, V., Hasan, S., et al. (2010) · Nature · doi:10.1038/nature09107 · Cited by 996
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Self-citationArtemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Metadata
- Authors
- Carrara, V. I., Zwang, J., Ashley, E. A., Price, R. N., Stepniewska, K., Barends, M., Brockman, A., Anderson, T., McGready, R., Phaiphun, L., Proux, S., van Vugt, M., Hutagalung, R., Lwin, K. M., Phyo, A. P., Preechapornkul, P., Imwong, M., Pukrittayakamee, S., Singhasivanon, P., White, N. J., & Nosten, F.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-23
- Volume
- 4
- Issue
- 2
- Pages
- e4551
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2010357659
- Cited by
- 281
- References
- 33
- FWCI
- 36.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.